2018 年第三季度报告 公司代码：600299 公司简称：安迪苏 蓝星安迪苏股份有限公司 2018 年第三季度报告 1 / 20 | 目录 | | --- | | 一、 | 重要提示 | 3 | | --- | --- | --- | | 二、 | 公司基本情况 | 3 | | 三、 | 重要事项 | 6 | | 四、 | 附录 | 9 | 2018 年第三季度报告 一、 重要提示 1.1 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和连带的法律责任。 1.2 公司全体董事出席董事会审议季度报告。 二、 公司基本情况 2.1 主要财务数据 单位：元 币种：人民币 | | 本报告期末 | 上年度末 | 本报告期末比上年度末增 | | | --- | --- | --- | --- | --- | | | | | 减(%) | | | 总资产 | 21,097,484,933 | 21,329,082,225 | -1% | | | 归属于上市公司 股东的净资产 | 13,524,109,026 | 13,164,279,7 ...

Financial Performance - The company's operating revenue for the first half of 2018 was CNY 5,749,988,088, representing a 17% increase compared to CNY 4,932,120,233 in the same period last year[24]. - The net profit attributable to shareholders of the listed company decreased by 15% to CNY 489,211,568 from CNY 577,370,721 in the previous year[24]. - Basic earnings per share decreased by 18% to CNY 0.18 compared to the same period last year[25]. - Weighted average return on equity fell to 3.75%, a decrease of 0.88 percentage points year-on-year[25]. - Operating profit decreased to CNY 899,025,861, down 13.9% from CNY 1,045,160,387 in the previous period[122]. - Net profit for the current period was CNY 638,190,560, a decrease of 13.4% compared to CNY 736,483,501 in the previous period[123]. - Total comprehensive income for the current period was CNY 455,143,905, down from CNY 1,289,130,192 in the previous period[123]. Cash Flow and Liquidity - The net cash flow from operating activities significantly dropped by 70% to CNY 364,737,893, down from CNY 1,207,291,875 in the same period last year[24]. - Cash and cash equivalents decreased by 35% to ¥5,016,686,121, representing 25% of total assets, primarily due to the acquisition of Nutriad[46]. - The net cash flow from operating activities for the first half of 2018 was ¥12,014,138, a decrease of 55.6% compared to ¥27,049,914 in the previous period[131]. - The ending balance of cash and cash equivalents was ¥2,635,091,968, an increase from ¥2,218,918,152 at the end of the previous period[131]. - The cash flow from financing activities resulted in a net outflow of ¥1,293,438,066, compared to a net outflow of ¥755,576,426 in the previous period, highlighting increased financing costs[128]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 20,295,408,804, a decrease of 5% from CNY 21,329,082,225 at the end of the previous year[24]. - Total current assets decreased to ¥8,833,648,986 from ¥11,164,248,898, indicating a reduction of approximately 20.9%[115]. - Total liabilities decreased from ¥4,072,008,374 to ¥3,621,718,369, a decline of about 11.06%[116]. - Owner's equity decreased from ¥17,257,073,851 to ¥16,673,690,435, a decrease of approximately 3.38%[117]. - The company reported a total inventory of ¥1,593,922,264, slightly down from ¥1,600,497,917, indicating a decrease of about 0.4%[115]. Research and Development - The company has a dedicated R&D team of approximately 200 people, emphasizing innovation in product development[27]. - Research and development expenses rose by 47% to RMB 178.66 million, reflecting the company's commitment to new product development for future growth[42][44]. - The company is actively developing its specialty products business, which is expected to have significant growth potential, and completed the acquisition of Nutriad in February 2018[40]. Market and Industry Trends - The global demand for high-quality animal protein is expected to increase due to a projected population of over 9 billion by 2050[28]. - The animal nutrition market is driven by increasing global meat consumption and the industrialization of the poultry industry[35]. - The company maintains a leading position in the global methionine market, being one of the few producers of both solid and liquid methionine[34]. Environmental and Social Responsibility - The company has committed to sustainable development by providing innovative products that improve animal health and reduce environmental impact[29]. - The company has increased its environmental protection investment by approximately RMB 40 million for various projects, including VOC online monitoring and odor management[94]. - The company has implemented a "zero odor" project to minimize environmental impact, identifying and addressing key odor sources in its facilities[92]. - The company has actively participated in poverty alleviation projects, donating RMB 100,000 to support local breeding industries in Gulang County[87]. Risks and Challenges - The company faces risks from global macroeconomic fluctuations, which could impact business performance and financial condition[54]. - The company relies on a limited number of suppliers for key raw materials, which poses a risk to business operations if supply is disrupted[61]. - Outbreaks of diseases in poultry or livestock can adversely affect the demand for nutritional additives, impacting the company's business and financial performance[64]. - The company faces foreign exchange risks due to its operations primarily outside China, with potential losses from currency fluctuations impacting financial performance[67]. Governance and Compliance - The financial report has been declared to be true, accurate, and complete by the company's management[6]. - The company has appointed KPMG Huazhen LLP as its accounting and internal control audit firm for the 2018 fiscal year, approved by the shareholders' meeting on April 25, 2018[81]. - The company has established a long-term incentive plan to attract and retain high-quality management personnel, aligning their interests with long-term shareholder value[82].

2018 年第一季度报告 公司代码：600299 公司简称：安迪苏 蓝星安迪苏股份有限公司 2018 年第一季度报告 1 / 18 | 一、 | 重要提示 3 | | --- | --- | | 二、 | 公司基本情况 3 | | 三、 | 重要事项 5 | | 四、 | 附录 8 | 2018 年第一季度报告 一、 重要提示 二、 公司基本情况 2.1 主要财务数据 本期安迪苏实现营业收入为 30.1 亿元人民币，同比增长 22%，这主要得益于液体蛋氨酸取得了两 位数的销量增长，而维生素业务也因为成功管理了由于中间体原料供应短缺引起的市场危机，对 营收做出了重要贡献，同时由于新产品开发和不断扩大的特种产品组合，其中包括 Nutriad 产品 组合带来的强劲增长。 3 / 18 单位：元 币种：人民币 本报告期末 上年度末 本报告期末比上年度末增 减(%) 总资产 21,564,702,802 21,329,082,225 1% 归属于上市公司 股东的净资产 13,430,321,345 13,164,279,736 2% 年初至报告期末 上年初至上年报告期末 比上年同期增减(%) 经营活动产生的 现金流量净 ...

Financial Performance - The company achieved a net profit attributable to shareholders of RMB 1,323,315,773 for the fiscal year 2017[5]. - The total distributable profit for the parent company as of December 31, 2017, was RMB 871,027,986[5]. - The board proposed a cash dividend of RMB 1.73 per 10 shares, totaling RMB 463,968,920.23, subject to shareholder approval[5]. - The company's operating revenue for 2017 was ¥10,397,823,108, a decrease of 3% compared to ¥10,688,263,140 in 2016[24]. - Net profit attributable to shareholders was ¥1,323,315,773, down 29% from ¥1,865,346,347 in 2016[24]. - Basic earnings per share decreased by 30% to ¥0.49 from ¥0.70 in 2016[25]. - The weighted average return on equity fell to 10.51%, a decrease of 6.28 percentage points from 16.79% in 2016[25]. - The operating cash flow for 2017 was CNY 2.51 billion, a decrease of 18% from CNY 3.05 billion in 2016[72]. - The gross profit margin for the overall business was 39%, reflecting a decrease of 8 percentage points compared to the previous year[79]. - The company's total cost of sales increased by 13% to RMB 6,350,759,160, influenced by rising raw material costs and increased sales volume[85]. Risk Management - The company reported no significant risks that could materially affect its operations during the reporting period[7]. - The report outlines various risks and countermeasures faced during operations, detailed in the section on operational discussion and analysis[7]. - The company has not engaged in any non-operational fund occupation by controlling shareholders or related parties[7]. - The company faces risks from global economic fluctuations, which could impact its operational performance and financial condition[142]. - The company relies on a limited number of suppliers for key raw materials, which poses a risk to its business if supply is disrupted[149]. - Customer credit risk remains a concern despite measures in place to manage exposure, indicating ongoing vulnerabilities in financial stability[157]. - The company is exposed to litigation risks related to product quality and intellectual property disputes, which could adversely affect its operations and reputation[160]. Research and Development - The company has a dedicated R&D team of approximately 200 people focused on developing innovative animal nutrition solutions[34]. - The company has established seven R&D centers globally, with a focus on developing specialty products as a key growth driver[37]. - The company signed a research cooperation agreement with Sichuan Agricultural University to enhance its R&D capabilities[93]. - Research and development expenses totaled RMB 300,228,195, accounting for 2.90% of total revenue, with 181 R&D personnel representing 9% of the total workforce[92]. - The company plans to launch three new products in 2018, leveraging the establishment of an innovation laboratory incubator[110]. Market Position and Strategy - The company is a global leader in methionine production, holding the second-largest market share globally in 2017, and is one of the few manufacturers capable of producing both solid and liquid methionine[36]. - The company has increased its market share in methionine from 24% in 2012 to 27% in 2017, despite new entrants and increased capacity from existing competitors[44]. - The company aims to maintain its leading position in the methionine market while accelerating the development of specialty products through its dual pillar strategy[58]. - The company achieved an 11% increase in methionine sales volume in 2017, exceeding the global market demand growth rate of 6%[73]. - The special products segment grew by 27% in 2017, reflecting the company's successful innovation and market promotion efforts[73]. Environmental and Social Responsibility - The company aims to reduce atmospheric pollutants from its MMP production unit by 25% to 50% through new technology[43]. - The company has invested significantly in environmental protection initiatives, including a "zero odor" project at its Nanjing plant to minimize environmental impact[189]. - The company is actively involved in poverty alleviation projects, focusing on education and local economic development in targeted poverty-stricken areas[185]. - The company emphasizes sustainable development and has implemented various innovative measures to fulfill corporate social responsibility, including employee satisfaction surveys[188]. Corporate Governance - The financial report is guaranteed to be true, accurate, and complete by the company's management[4]. - The company has implemented a long-term incentive plan to attract and retain high-quality management personnel[178]. - The company has maintained a stable and transparent profit distribution policy to enhance operational performance and shareholder value[167]. - The company has not faced any risks of suspension or termination of its listing during the reporting period[176]. - The company has engaged KPMG Huazhen as its domestic auditor with a remuneration of RMB 2.1 million for the audit period[175].

2017 年第三季度报告 公司代码：600299 公司简称：安迪苏 蓝星安迪苏股份有限公司 2017 年第三季度报告 1 / 20 | 目录 | | --- | | 一、 | 重要提示 | 3 | | --- | --- | --- | | 二、 | 公司基本情况 | 3 | | 三、 | 重要事项 | 6 | | 四、 | 附录 | 9 | 2017 年第三季度报告 一、 重要提示 1.1 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和连带的法律责任。 1.2 公司全体董事出席董事会审议季度报告。 二、 公司基本情况 2.1 主要财务数据 单位：元 币种：人民币 尽管市场环境面临挑战，得益于蛋氨酸销量增加，全球奶业危机结束后过瘤胃保护性蛋氨酸销量 增加，以及维生素 A 和 B 族提价和卓有成效的成本控制，安迪苏最终实现了 21%的营业利润率。 营业收入为 76.2 亿元人民币，归属于上市公司股东的净利润为 9 亿元人民币，净利润率为 12%。 经营活动现金净流入为 15.9 亿人民币，使得安迪苏可以更好地为自身发展提供资 ...

Financial Performance - The company's operating revenue for the first half of 2017 was CNY 4,932,120,233, representing a decrease of 9% compared to CNY 5,434,956,134 in the same period last year[19]. - The net profit attributable to shareholders of the listed company was CNY 577,370,721, down 48% from CNY 1,101,539,701 in the previous year[19]. - The net cash flow from operating activities was CNY 1,207,291,875, a decrease of 20% compared to CNY 1,513,959,890 in the same period last year[19]. - Basic earnings per share decreased by 46% to CNY 0.22 compared to the same period last year[20]. - Diluted earnings per share also decreased by 46% to CNY 0.22 compared to the same period last year[20]. - The weighted average return on equity fell by 5.44 percentage points to 4.63% compared to the same period last year[20]. - The company reported a total of CNY 4,307,684 in non-recurring gains, primarily from government subsidies and insurance claims[22]. - The company reported a decrease in current liabilities to CNY 1,956,689,079 from CNY 2,438,905,959, a decline of approximately 19.69%[95]. - The company’s retained earnings stood at CNY 7,726,710,185, down from CNY 7,766,000,584, indicating a decrease of about 0.51%[96]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 20,208,964,527, an increase of 1% from CNY 19,943,821,352 at the end of the previous year[19]. - The total liabilities decreased to CNY 3,708,370,813 from CNY 4,056,803,086, a reduction of about 8.57%[95]. - Owner's equity rose to CNY 16,500,593,714, compared to CNY 15,887,018,266, indicating an increase of approximately 3.86%[96]. - The company’s total assets and liabilities have been reported in accordance with the Chinese accounting standards, ensuring compliance and transparency[133]. Operational Risks - There were no significant risks that materially affected the company's production and operation during the reporting period[4]. - The company faces risks from global macroeconomic fluctuations, which could impact its operational performance and financial condition[45]. - Supply-demand imbalances in the methionine market may affect product availability and pricing, influenced by global capacity changes[46]. - Competitive pressures from large firms and smaller entrants necessitate cost control and production efficiency improvements[47]. - The company is exposed to risks associated with cross-border operations, including regulatory changes and geopolitical factors[48]. - Environmental regulations may lead to increased costs if stricter pollution standards are implemented in the countries where the company operates[49]. - The company relies on a limited number of suppliers for key raw materials, which poses risks if supply is disrupted or prices fluctuate significantly[51]. - The company faces customer credit risk despite implementing measures such as account establishment and credit limit settings[59]. - Tax and tariff changes pose risks, as the company may lose previously obtained tax benefits due to government audits[60]. Research and Development - Research and development expenses increased by 57% to CNY 121,685,278, reflecting the company's commitment to process improvements and new product development[36]. - The company has over 600 patents, showcasing its strong research and development capabilities[32]. - The company launched a revolutionary new product, Rodyme® A-Dry+, a powdered methionine product developed from liquid methionine technology[26]. - The company is actively expanding its specialty products business, which is seen as a significant growth opportunity[37]. Market Position - The company is a global leader in methionine production, holding the second-largest market share globally in 2017[24]. - The animal nutrition market is driven by increasing global meat consumption, particularly in the poultry feed sector[27]. - The company has a strong market presence, providing products to over 140 countries and regions, and is recognized as a leader in the feed additive industry[32]. Financial Management - The company has implemented long-term incentive plans to attract and retain high-quality management personnel for its global development[75]. - The company committed to achieving a net profit of RMB 792,267,000 after deducting non-recurring gains and losses for 2017, based on the profit forecast and compensation agreement[76]. - The company has maintained compliance with environmental regulations at its Nanjing factory, continuously increasing investments in environmental protection[79]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 23,947[82]. - The total number of shares held by China BlueStar (Group) Co., Ltd. is 2,389,387,160, accounting for 89.09% of the total shares[84]. - The company reported a profit distribution of 58,348,568, which includes allocations to surplus reserves and general risk provisions[118]. - The company’s capital reserve increased by 196,018,000 during the period, contributing to the overall equity growth[118]. Accounting and Compliance - The financial report has not been audited[4]. - There were no changes in the company's accounting policies or estimates during the reporting period[80]. - The company has not experienced any major accounting errors that require restatement during the reporting period[80]. - The company has no significant changes in its share capital structure during the reporting period[81].